Evidence map›Paper›PMID 41970847›Full record

ArticleACS omega2026

Bisamidine Derivatives as Candidates for Tegumentary Leishmaniasis Therapy: Phenotypic Screening in Infection of Macrophages and Mechanistic Insights with Dual RNA-seq.

Joice Agripino, Ana C Tahira, Luciana Ângelo de Souza, Matheus Silva E Bastos, Benjamin Sauer, Matthias Schmidt, Gustavo Costa Bressan, Raphael de Souza Vasconcellos, Wolfgang Sippl, Raymond Pierce and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Joice AgripinoBiochemistry and Molecular Biology Department, Universidade Federal de Viçosa, Viçosa 36570-900, Brazil.
Ana C TahiraLaboratory of Cell Cycle, Instituto Butantan, São Paulo, SP 05503-900, Brazil.
Luciana Ângelo de SouzaGeneral Biology Department, Universidade Federal de Viçosa, Viçosa 36570-900, Minas Gerais, Brazil.
Matheus Silva E BastosBiochemistry and Molecular Biology Department, Universidade Federal de Viçosa, Viçosa 36570-900, Brazil.
Benjamin SauerInstitute of Pharmacy, Martin-Luther-University of Halle-Wittenberg, Halle (Saale) 06120, Germany.
Matthias SchmidtInstitute of Pharmacy, Martin-Luther-University of Halle-Wittenberg, Halle (Saale) 06120, Germany.
Gustavo Costa BressanBiochemistry and Molecular Biology Department, Universidade Federal de Viçosa, Viçosa 36570-900, Brazil.ORCID https://orcid.org/0000-0002-9741-4554
Raphael de Souza VasconcellosBiochemistry and Molecular Biology Department, Universidade Federal de Viçosa, Viçosa 36570-900, Brazil.ORCID https://orcid.org/0000-0002-5064-052X
Wolfgang SipplInstitute of Pharmacy, Martin-Luther-University of Halle-Wittenberg, Halle (Saale) 06120, Germany.ORCID https://orcid.org/0000-0002-5985-9261
Raymond PierceUniversité de Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 8204 - CIIL - Centre d'Infection et d'Immunité de Lille, 59000 Lille, France.
Murilo Sena AmaralLaboratory of Cell Cycle, Instituto Butantan, São Paulo, SP 05503-900, Brazil.
Sergio Verjovski-AlmeidaLaboratory of Cell Cycle, Instituto Butantan, São Paulo, SP 05503-900, Brazil.ORCID https://orcid.org/0000-0002-6356-2401
Juliana Lopes Rangel FiettoBiochemistry and Molecular Biology Department, Universidade Federal de Viçosa, Viçosa 36570-900, Brazil.ORCID https://orcid.org/0000-0001-6122-1710

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41970847
PMCPMC13063000

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.